Hutch News

Hutch News

Stories tagged 'SWOG'

Dr. James Dai receives $2.1M NCI grant for cancer biomarker research

Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment

Aug. 20, 2018 | By Colin Petersdorf / Fred Hutch News Service

Fred Hutch biostatistician Dr. James Dai recently was awarded a $2.1 million grant from the National Cancer Institute to develop new analytical methods for identifying genetic and epigenetic alterations that drive cancers. He hopes this work will facilitate the discovery of molecular cancer drivers — biomarkers — and the development of new preventive, diagnostic and prognostic techniques.

View story >


Closing the rural-urban cancer survival gap

‘Guideline care’ in clinical trials erased cancer death-rate disparities

Aug. 17, 2018 | By Sabin Russell / Fred Hutch News Service

Cancer patients in rural areas of the United States die of their disease at significantly higher rates than those residing in U.S. cities, and scientists at Fred Hutch are trying to find out why.

View story >


Dr. Yingqi Zhao receives SWOG Coltman Fellowship early-career award

She plans to use the funds to develop new surveillance and diagnostic strategies for immunotherapy trials

Aug. 8, 2018 | By Colin Petersdorf / Fred Hutch News Service

Fred Hutchinson Cancer Research Center biostatistician Dr. Yingqi Zhao has been awarded the Dr. Charles A. Coltman Jr. Fellowship, which recognizes and funds prolific early- and mid-career scientists from affiliated institutions within SWOG, a national clinical trials network.

View story >


Acupuncture can curb treatment-related joint pain in breast cancer patients

Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug

July 10, 2018 | By Diane Mapes / Fred Hutch News Service

Results from a large multicenter trial published today in JAMA offer good news to early stage breast cancer patients dealing with painful side effects from powerful estrogen-squelching drugs known as aromatase inhibitors.

View story >


Finasteride can reduce prostate cancer risk long term

Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss

March 21, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch public health researcher Dr. Joe Unger used an innovative trial design to confirm finasteride, a drug used to treat enlarged prostate or hair loss in men, has a long-term protective effect against prostate cancer.

View story >


Matching up cancer risk with reality

New examination of prostate cancer data identifies ‘detection bias’ in prostate studies

Oct. 31, 2016 | By Diane Mapes / Fred Hutch News Service

A new Fred Hutch-led study suggests variation in prostate cancer biopsy patterns, i.e., who does and who doesn't get screened, may have colored our perception of risk for the disease.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.